Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15–17 November 2007
- 58 Downloads
The discussion on breast cancer immunotherapy at this first ESMO-supported ESCII conference in Athens was perhaps appropriate given that the very name “cancer” derives from the ancient Greeks’ observations on the external manifestations of breast tumours, with Galen noting that the veins in breast cancer are dilated and similar in appearance to crabs’ legs on both sides of the body, indicating presence of the tumour. Important modern concepts and therapeutic targets of inflammation and angiogenesis were presaged by their observations, and the effect of diet on causation was also perceived. This 2-day meeting, 2000+ years later, considered the current position of immunotherapy from many points of view, including the issue of cancer and inflammation, adoptive therapy by antibodies and cells, active immunotherapy with vaccines and the critical role of immunity versus tolerance. We present here a brief personal view of the highlights of the meeting, organised by H. Mellstedt, Stockholm,...
KeywordsCervical Cancer Adoptive Immunotherapy Active Immunotherapy Early Stage Breast Cancer Patient Super Paramagnetic Iron Oxide
- 9.Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 100:8372–8377PubMedCrossRefGoogle Scholar
- 12.De Vries IJ, Bernsen MR, van Geloof WL, Scharenborg NM, Lesterhuis WJ, Rombout PD, Van Muijen GN, Figdor CG, Punt CJ, Ruiter DJ, Adema GJ (2007) In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Cancer Immunol Immunother 56:1667–1676PubMedCrossRefGoogle Scholar
- 13.Santegoets SJ, Schreurs MW, Masterson AJ, Liu YP, Goletz S, Baumeister H, Kueter EW, Lougheed SM, van den Eertwegh AJ, Scheper RJ, Hooijberg E, de Gruijl TD (2006) In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunol Immunother 55:1480–1490PubMedCrossRefGoogle Scholar
- 14.Kiessling R, De Geer A, Johansson C, Poschke I, Triulzi C, Vertuani S (2007) Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10–11, 2007. Cancer Immunol Immunother Nov 20; [Epub ahead of print]Google Scholar